Indication Taxonomy Review
19 therapeutic areas, 158 indications
Coverage: 80,780 / 267,124 condition mentions matched (30.2%)
Oncology
40 indications 34,847 trials
Solid Tumor (Advanced) (4,806 trials)
Breast Cancer (3,157 trials)
NSCLC (2,479 trials)
Colorectal Cancer (1,923 trials)
Prostate Cancer (1,643 trials)
Non-Hodgkin Lymphoma (1,627 trials)
Multiple Myeloma (1,464 trials)
Melanoma (1,169 trials)
AML (1,165 trials)
Head and Neck Cancer (1,095 trials)
Pancreatic Cancer (1,052 trials)
Ovarian Cancer (1,019 trials)
Hepatocellular Carcinoma (1,012 trials)
MDS (872 trials)
Gastric Cancer (841 trials)
Glioblastoma (768 trials)
Lung Cancer (General) (747 trials)
Esophageal Cancer (649 trials)
Bladder Cancer (638 trials)
Sarcoma (638 trials)
Hematologic Malignancies (569 trials)
Renal Cell Carcinoma (530 trials)
CLL (506 trials)
Cholangiocarcinoma (450 trials)
ALL (416 trials)
Cervical Cancer (399 trials)
Endometrial Cancer (387 trials)
Triple Negative Breast Cancer (369 trials)
Brain Tumor (350 trials)
SCLC (326 trials)
Hodgkin Lymphoma (280 trials)
Myelofibrosis (247 trials)
Neuroendocrine Tumors (242 trials)
CML (197 trials)
HER2+ Breast Cancer (176 trials)
Mesothelioma (159 trials)
Squamous Cell Carcinoma (155 trials)
Thyroid Cancer (147 trials)
HER2- Breast Cancer (104 trials)
Merkel Cell Carcinoma (74 trials)
CNS
18 indications 8,469 trials
Major Depression (1,398 trials)
Alzheimer's Disease (1,396 trials)
Schizophrenia (856 trials)
Parkinson's Disease (752 trials)
Multiple Sclerosis (555 trials)
Alcohol Use Disorder (451 trials)
Opioid Use Disorder (418 trials)
Migraine (369 trials)
Anxiety (330 trials)
Autism Spectrum Disorder (325 trials)
Epilepsy (313 trials)
ALS (295 trials)
Bipolar Disorder (272 trials)
ADHD (246 trials)
PTSD (234 trials)
Huntington's Disease (102 trials)
Neuropathy (93 trials)
OCD (64 trials)
Metabolic
7 indications 7,587 trials
Type 2 Diabetes (2,660 trials)
Obesity (1,682 trials)
Diabetes (General) (978 trials)
Type 1 Diabetes (797 trials)
Dyslipidemia (547 trials)
Diabetic Complications (497 trials)
NASH/NAFLD (426 trials)
Infectious Disease
13 indications 6,875 trials
COVID-19 (1,962 trials)
HIV (1,338 trials)
Influenza (806 trials)
Hepatitis C (694 trials)
Hepatitis B (488 trials)
Sepsis (486 trials)
Malaria (372 trials)
Tuberculosis (290 trials)
H. pylori (158 trials)
Bacterial Infections (115 trials)
Fungal Infections (85 trials)
RSV (75 trials)
C. difficile (6 trials)
Cardiovascular
9 indications 5,151 trials
Hypertension (1,426 trials)
Stroke (930 trials)
Coronary Artery Disease (915 trials)
Heart Failure (851 trials)
Atrial Fibrillation (365 trials)
Myocardial Infarction (299 trials)
Thrombosis (273 trials)
Arrhythmia (56 trials)
Hypertrophic Cardiomyopathy (36 trials)
Immunology
15 indications 4,744 trials
Rheumatoid Arthritis (974 trials)
Psoriasis (865 trials)
Atopic Dermatitis (753 trials)
Crohn's Disease (484 trials)
Ulcerative Colitis (414 trials)
Lupus (332 trials)
Psoriatic Arthritis (131 trials)
Myasthenia Gravis (130 trials)
Lupus Nephritis (120 trials)
Hidradenitis Suppurativa (111 trials)
IgA Nephropathy (105 trials)
Chronic Spontaneous Urticaria (99 trials)
Ankylosing Spondylitis (89 trials)
IBD (82 trials)
NMOSD (55 trials)
Respiratory
7 indications 3,291 trials
Asthma (1,234 trials)
COPD (927 trials)
Cystic Fibrosis (432 trials)
Idiopathic Pulmonary Fibrosis (265 trials)
Allergic Rhinitis (195 trials)
Pneumonia (170 trials)
Chronic Rhinosinusitis with Nasal Polyps (68 trials)
Pain
4 indications 2,718 trials
Acute Pain (1,300 trials)
Postoperative Pain (995 trials)
Chronic Pain (281 trials)
Neuropathic Pain (142 trials)
Rare Disease
9 indications 1,087 trials
Sickle Cell Disease (362 trials)
Hemophilia (240 trials)
Immune Thrombocytopenia (191 trials)
Duchenne Muscular Dystrophy (143 trials)
Fabry Disease (62 trials)
Spinal Muscular Atrophy (44 trials)
Gaucher Disease (26 trials)
Mastocytosis (15 trials)
CDKL5 Deficiency Disorder (4 trials)
Women's Health
5 indications 1,051 trials
Infertility (368 trials)
Contraception (192 trials)
PCOS (178 trials)
Menopause (165 trials)
Endometriosis (148 trials)
Musculoskeletal
4 indications 831 trials
Osteoarthritis (291 trials)
Osteoporosis (279 trials)
Gout (208 trials)
Muscle Spasm (53 trials)
Renal
2 indications 790 trials
Chronic Kidney Disease (599 trials)
Acute Kidney Injury (191 trials)
Ophthalmology
3 indications 781 trials
Dry Eye (348 trials)
Glaucoma (268 trials)
Age-Related Macular Degeneration (165 trials)
Dermatology
5 indications 748 trials
Acne (357 trials)
Alopecia (199 trials)
Vitiligo (76 trials)
Rosacea (73 trials)
Skin Infections (43 trials)
Gastrointestinal
5 indications 640 trials
Nausea/Vomiting (168 trials)
Constipation (163 trials)
GERD (126 trials)
Diarrhea (116 trials)
Peptic Ulcer (67 trials)
Urology
3 indications 496 trials
Overactive Bladder (222 trials)
Erectile Dysfunction (167 trials)
Benign Prostatic Hyperplasia (107 trials)
Hepatology
2 indications 285 trials
Cirrhosis (236 trials)
Liver Failure (49 trials)
Sleep
2 indications 220 trials
Insomnia (179 trials)
Narcolepsy (41 trials)
Endocrine
5 indications 169 trials
Acromegaly (50 trials)
Growth Hormone Deficiency (41 trials)
Hypothyroidism (27 trials)
Adrenal Insufficiency (26 trials)
Hyperthyroidism (25 trials)
How to use: Review each therapeutic area and its indications. Click "▼ aliases" to see which condition names map to each canonical indication.
Zero counts: Gray aliases haven't been seen in trial data yet (may be rare or spelling variations).
Edit taxonomy: scripts/indication-taxonomy.js